A study published in the Journal of Cancer Survivorship found that cancer survivors receiving high-cost immunotherapy ...

The Trump administration is already gearing up for another round of Medicare drug price negotiations, while OpenAI launched a ...

Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...

Remote symptom monitoring in cancer care reduces hospitalizations, enhances value-based care, and supports diverse patient ...

Tribal officials and some congressional leaders say cuts to federal health programs have not included input from Native ...

The best Medicare plans for cancer patients are a Medigap Plan G from AARP and a Medicare Part D plan from Wellcare. Alternatively, if your cancer diagnosis means you can't qualify for Medigap, choose ...

Researchers projected CT use in 2023 would lead to more than 100,000 future cancer diagnoses, and if trends continued, may ...

Investing in patient navigation and clinician incentives ensures colorectal cancer screening completion, improves early detection, reduces disparities, achieves cost savings, and advances population ...

In patients with venous thromboembolism (VTE) who are candidates for oral anticoagulation, apixaban results in fewer ...

The U.S. Centers for Medicare and Medicaid Services (CMS) said on Monday that it would announce a list of 15 drugs eligible ...

The order is based on a "most favored nation" pricing model, which is similar to a policy Trump pushed in his first ...

His proposal would likely only impact certain drugs covered by Medicare and given in an office — think infusions that treat ...